Actinium Pharmaceuticals, Inc. (ATNM)

1.13 +0.02 (+1.80%) USD  |  NYAM  |  Feb 20, 09:57
More

Actinium Pharmaceuticals Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for ATNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Assertio Holdings, Inc. Upgrade
Altimmune, Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
Avanos Medical, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade